Search
for
Sort by
Research 481–510 of 1000+
- Overexpression of IL-18 in the Proliferative Phase Endometrium of Patients With Polycystic Ovary Syndrome
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Phytochemical, Toxicological and Pharmacological Studies of <i>Asiasari Radix</i> et Rhizoma: A Review
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Body image and mental health in women with polycystic ovary syndrome–a cross-sectional study
- Hirsutism in the Adolescent Female
- A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2
- Adipose and Hair Function: An aPPARent Connection
- Endocrine evaluation of hirsutism
- Steroid Hormones
- Clinical use of 5α-reductase inhibitors
- Evaluation of Sleep Quality, Restless Legs Syndrome, Anxiety and Depression in Polycystic Ovary Syndrome
- Polycystic ovary syndrome: An update on diagnosis and management
- The Quantification of Terminal Hair by Digital Microscopy: Advancements Towards a More Objective Diagnosis of Hirsutism
- Biology of Hair Growth and Influence of External Factors (Ecology, Stress, Nutrition
- The Effects of Metformin, Ethinyl Estradiol/Cyproterone Acetate, and Metformin Ethinyl Estradiol/Cyproterone Acetate Combination Therapy on Carotid Artery Intima-media Thickness in Patients with Polycystic Ovary Syndrome
- Androgenic Hormone Profile of Adult Women with Acne
- Hyperandrogenism in polycystic ovary syndrome and adrenal hyperplasia: finding differences to make a specific diagnosis
- Clinical manifestations of polycystic ovary syndrome
- Effect of finasteride on ovulation induction in nonresponder (hyperandrogenic) polycystic ovary syndrome (PCOS) women
- A comparative study on insulin resistance in females of reproductive age group with acne vulgaris
- A Prospective Hospital-Based Study on Cutaneous Manifestations in Patients with Polycystic Ovarian Syndrome (PCOS)
- Pattern of dyslipidemia among adult women with polycystic ovary syndrome in Port Harcourt, Nigeria
- CUTANEOUS MANIFESTATIONS OF POLYCYSTIC OVARIAN DISEASE
- Deletion of Deoxyribonucleic Acid Binding Domain of the Vitamin D Receptor Abrogates Genomic and Nongenomic Functions of Vitamin D
- ATP-competitive mTOR kinase inhibitors delay plant growth by triggering early differentiation of meristematic cells but no developmental patterning change
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Adiponectin Signaling Regulates Lipid Production in Human Sebocytes
- Hormone therapy in acne